BiotechTube
Home/AccurEdit Therapeutics/Yongzhong Wang, Ph.D.
YW

Yongzhong Wang, Ph.D.

Founder, Chairman and CEO

AccurEdit Therapeutics

Therapeutic Areas

Genetic DiseasesCardiovascular

AccurEdit Therapeutics Pipeline

DrugIndicationPhase
ART001ATTR (Transthyretin Amyloidosis)Phase 1